162 related articles for article (PubMed ID: 22072582)
21. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
Guzel S; Kiziler L; Aydemir B; Alici B; Ataus S; Aksu A; Durak H
Biol Trace Elem Res; 2012 Jan; 145(1):23-32. PubMed ID: 21809052
[TBL] [Abstract][Full Text] [Related]
22. Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
Bergström SH; Järemo H; Nilsson M; Adamo HH; Bergh A
Prostate; 2018 Mar; 78(4):257-265. PubMed ID: 29250809
[TBL] [Abstract][Full Text] [Related]
23. Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto's thyroiditis and hypothyroidism.
Nourbakhsh M; Ahmadpour F; Chahardoli B; Malekpour-Dehkordi Z; Nourbakhsh M; Hosseini-Fard SR; Doustimotlagh A; Golestani A; Razzaghy-Azar M
J Trace Elem Med Biol; 2016 Mar; 34():10-4. PubMed ID: 26854239
[TBL] [Abstract][Full Text] [Related]
24. Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma.
Zhang J; Dong WG; Lin J
Med Oncol; 2011 Jun; 28(2):481-7. PubMed ID: 20354826
[TBL] [Abstract][Full Text] [Related]
25. Influence of gender on selenoprotein W, glutathione peroxidase and selenium in tissues of rats.
Yeh JY; Ou BR; Gu QP; Whanger PD
Comp Biochem Physiol B Biochem Mol Biol; 1998 Jan; 119(1):151-5. PubMed ID: 9530816
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome.
Cattrini C; Rubagotti A; Nuzzo PV; Zinoli L; Salvi S; Boccardo S; Perachino M; Cerbone L; Vallome G; Latocca MM; Zanardi E; Boccardo F
Clin Genitourin Cancer; 2018 Dec; 16(6):e1257-e1265. PubMed ID: 30170989
[TBL] [Abstract][Full Text] [Related]
27. [Relation between selenium plasma levels and different prostatic pathologies].
López Fontana CM; Pérez Elizalde RF; Vanrell MC; Recalde GM; Uvilla AL; López Laur JD
Actas Urol Esp; 2010 Jul; 34(7):625-9. PubMed ID: 20540880
[TBL] [Abstract][Full Text] [Related]
28. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
[TBL] [Abstract][Full Text] [Related]
29. Selenium, selenoproteins and selenometabolites in mothers and babies at the time of birth.
Santos C; García-Fuentes E; Callejón-Leblic B; García-Barrera T; Gómez-Ariza JL; Rayman MP; Velasco I
Br J Nutr; 2017 May; 117(9):1304-1311. PubMed ID: 28534447
[TBL] [Abstract][Full Text] [Related]
30. Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the Gleason score.
Nishiyama T; Ikarashi T; Hashimoto Y; Suzuki K; Takahashi K
J Urol; 2006 Oct; 176(4 Pt 1):1387-91. PubMed ID: 16952639
[TBL] [Abstract][Full Text] [Related]
31. Role of SELENBP1 and SELENOF in prostate cancer bioenergetics.
Bera S; Diamond AM
Arch Biochem Biophys; 2022 Dec; 732():109451. PubMed ID: 36334799
[TBL] [Abstract][Full Text] [Related]
32. Expression of stem cell marker CD44 in prostate cancer biopsies predicts cancer grade in radical prostatectomy specimens.
Korski K; Malicka-Durczak A; Bręborowicz J
Pol J Pathol; 2014 Dec; 65(4):291-5. PubMed ID: 25693083
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.
Méplan C; Rohrmann S; Steinbrecher A; Schomburg L; Jansen E; Linseisen J; Hesketh J
PLoS One; 2012; 7(11):e48709. PubMed ID: 23133653
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.
Josefsson A; Adamo H; Hammarsten P; Granfors T; Stattin P; Egevad L; Laurent AE; Wikström P; Bergh A
Am J Pathol; 2011 Oct; 179(4):1961-8. PubMed ID: 21854754
[TBL] [Abstract][Full Text] [Related]
35. The Proteome of Primary Prostate Cancer.
Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 Tat protein impairs selenoglutathione peroxidase expression and activity by a mechanism independent of cellular selenium uptake: consequences on cellular resistance to UV-A radiation.
Richard MJ; Guiraud P; Didier C; Seve M; Flores SC; Favier A
Arch Biochem Biophys; 2001 Feb; 386(2):213-20. PubMed ID: 11368344
[TBL] [Abstract][Full Text] [Related]
37. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
Chan JM; Oh WK; Xie W; Regan MM; Stampfer MJ; King IB; Abe M; Kantoff PW
J Clin Oncol; 2009 Aug; 27(22):3577-83. PubMed ID: 19528373
[TBL] [Abstract][Full Text] [Related]
38. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model.
Tollefson MK; Karnes RJ; Kwon ED; Lohse CM; Rangel LJ; Mynderse LA; Cheville JC; Sebo TJ
Mayo Clin Proc; 2014 Mar; 89(3):308-18. PubMed ID: 24486077
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy.
Mao Y; Li K; Lu L; Si-Tu J; Lu M; Gao X
Cancer Biomark; 2016; 16(3):351-8. PubMed ID: 26889981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
